Thiazolidinediones in the treatment of Type 2 diabetes

Author： Greenberg Andrew S   Pittas Anastassios G  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.5, 2002-05, pp. : 529-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes

By Schwartz Ann V   Sellmeyer Deborah E  

Expert Opinion on Drug Safety, Vol. 7, Iss. 1, 2008-01 ,pp. : 69-78

Informa Healthcare

Access to resources Recommend Favorite

Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence

By Diamant M.   Heine R.J.  

Drugs, Vol. 63, Iss. 13, 2003-01 ,pp. : 1373-1405

Adis International

Access to resources Recommend Favorite

Thiazolidinediones Anti-Inflammatory and Anti-Atherosclerotic Effects in Type 2 Diabetes Mellitus

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1498-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Dapagliflozin for the treatment of type 2 diabetes

By Abdul-Ghani Muhammad A   DeFronzo Ralph A  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1695-1703

Informa Healthcare

Access to resources Recommend Favorite